Open Access Repository

Repository Statistics - Deposits

All items > Item: Cost-effectiveness of domestic PD-1 inhibitor Camrelizumab combined with chemotherapy in the first-line treatment of advanced nonsquamous non–small-cell lung cancer in China
Deposits (Archive)
Type of resources
File formats
TOP